NIC
UTHR icon

Northwest Investment Counselors’s United Therapeutics UTHR Stock Holding History

Northwest Investment Counselors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21
Closed -$4.74K – 512
2023
Q3 		$4.74K Hold
21
– – ﹤0.01% 445
2023
Q2 		$4.64K Buy
+21
New +$4.65K ﹤0.01% 456

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwest Investment Counselors's UTHR Position: Q4 2023 in Review

Northwest Investment Counselors sold out of United Therapeutics (UTHR) in Q4 2023, closing a stake of 21 shares — an estimated $4.74K sold.

Northwest Investment Counselors first reported a position in UTHR in Q2 2023 and held it in 2 quarters. The position peaked at $4.74K in Q3 2023. 535 funds tracked by Wall St. Rank hold UTHR as of Q4 2023.

  • Northwest Investment Counselors reported no remaining United Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Northwest Investment Counselors sold 21 United Therapeutics shares in Q4 2023, an estimated $4.74K.
  • Northwest Investment Counselors first reported a position in United Therapeutics in Q2 2023 and held it in 2 quarters.
  • Northwest Investment Counselors's United Therapeutics position peaked at $4.74K in Q3 2023.
  • 535 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2023.

Based on Northwest Investment Counselors's 13F filing for Q4 2023, filed 19 Jan 2024.